• English
  • Español

Sesión de Pósteres 2

Sesión de Pósteres 2
Viernes 21 Octubre 11, 10:30-11:15h

Methods for preparing reviews (non-statistical) (P2A135-P2A196)

Investigating bias (P2A197-P2A202)

Investigating bias (P2B203-P2B260)

Diagnostic test accuracy review methods (P2B261-P2B271)

 

LatinCLEN Sesión de Pósteres 1
Viernes 21 Octubre 11, 10:30-11:15h


Methods for preparing reviews (non-statistical) (P2A135-P2A196) – (Vestíbulo 1er piso)

●         P2A135: The COMET (Core Outcome Measures in Effectiveness Trials) Initiative. Williamson P, Altman D, Blazeby J, Clarke M, Gargon E.

●         P2A136: Purity or pragmatism: how does systematic review methodology from health care translate to the field of development? Stewart R, van Rooyen C, de Wet T.

●         P2A137: Reviewing psychometric properties of HRQL measures in mental health: practical experience. Papaioannou D, Brazier J.

●         P2A138: External validity and generalizability of systematic reviews in primary health care: adapting the methodology to conduct the review. Nasser M, van Binsbergen JJ, van de Laar FA, van Weel C, Buechter R.

●         P2A139: Prioritising whether and when to update Cochrane reviews. Hopewell S, Takwoingi Y, Sutton A.

●         P2A141: Estimating risk differences in patient-important events when studies have focused on surrogate outcomes: application to systematic reviews and practice guidelines. Guyatt G, Akl E, Murad MH, Falck-Ytter Y, Gould M, Eikelboom J.

●         P2A142: The evidence base for interventions delivered to children in primary care: an overview of Cochrane systematic reviews. Gill P, Wang KY, Mant D, Hartling L, Heneghan C, Perera R, Klassen T, Harnden A.

●         P2A143: Variability of outcome measures among trials of topical Chinese herbal medicines for musculoskeletal injuries. Wang L, Yuan Q, Li X, Li Y.

●         P2A144: Still too little qualitative research to shed light on results from reviews of effectiveness trials: A case study of a Cochrane review on the use of lay health workers. Glenton C, Lewin S, Scheel I.

●         P2A145: Guidelines for conducting and reporting reviews of reviews: Dealing with topic relevance and double-counting. O’Mara AJ, Jamal F, Parry W, Lorenc T, Cooper C.

●         P2A146: Using EpiData software to extract data for Cochrane systematic review. Liu Z, Li X, Visconte D, Lewith G, Liu J.

●         P2A147: Indirect meta-analysis of uncontrolled studies about two independent regimes: an case report. Sun T, Wang J, Fang J.

●         P2A148: A rapid systematic review versus a Cochrane systematic review: an empirical comparison. Rizzo M, Llewellyn A, Martin A.

●         P2A149: Development and Evaluation of a Study Designs Typology for Medical Literature of Intervention. Seo HJ, Kim SY, Park JE, Lee YJ, Shin SS, Hahn SK.

●         P2A150: Validation and application of a systematic review and narrative synthesis within mental health services research. Bird V, Leamy M, Williams J, Le Boutillier C, Slade M.

●         P2A151: Systematic review and synthesis of quantitative and qualitative research: a worked example to assess community preferences. Tong A, Howard K, Jan S, Cass A, Rose J, Chadban S, Allen R, Craig J.

●         P2A152: Causal mapping for systematic reviews of complex social interventions. Lorenc T, Clayton S, Neary D, Petticrew M, Whitehead M.

●         P2A153: A worked example of “best fit” framework synthesis: A potentially more consistent or reliable form of qualitative data synthesis? Booth A, Cooper K.

●         P2A154: Mixed-methods synthesis for community-level public health interventions: Some considerations from a review of skin cancer prevention. Lorenc T, Jamal F, O’Mara A, Cooper C.

●         P2A155: Overviews of systematic reviews often do not assess methodological quality of included reviews. Büchter R, Pieper D, Jerinic P.

●         P2A156: The data was unobtainable - a survey of the reporting of missing data in a sample of Cochrane reviews. Struthers C, Noel-Storr A.

●         P2A157: Mixing with the ‘unclean’: including non-Cochrane reviews alongside Cochrane reviews in overviews of reviews. Foisy M, Becker LA, Chalmers JR, Boyle RJ, Simpson EL, Williams HC.

●         P2A158: Risk difference estimation and reporting in systematic reviews. Alonso-Coello P, Neumann I, Carrasco-Labra A, Brignardello-Petersen R, Irfan A, Solà I, Dahm P, Glujovsky D, Johnston B, Martinez L, Ramirez-Morera A, Sun X, Vandvik PO, Akl E, Tikkinen KA, Iorio A, Santesso N, Brozek J, Schünemann H, Guyatt G.

●         P2A159: Using Qualitative Evidence to Inform a Review of Effectiveness: A Case Study of Integrating Qualitative Data in a Systematic Review of Effectiveness of ECT for Adult Depression. Berg R, Leiknes KA, Hoie B.

●         P2A160: Methodological Perspectives on a Realist Synthesis: An Explanatory Analysis of the Effectiveness of Female Genital Mutilation/Cutting (FGM/C) Abandonment Efforts. Berg R, Denison E.

●         P2A161: New and emerging methods of research synthesis: are they given sufficient attention? Petrova M.

●         P2A162: Feasibility of fast track systematic review for policy makers: interchangeability between pneumococcal conjugate vaccines. Ciapponi A, García Martí S, Rey-Ares L, Glujovsky D, Bardach A, Valanzasca P, Lee A, Cafferata ML.

●         P2A163: Use of WOMAC for the assessment of treatment benefit for the pain of osteoarthritis of the knee. Woolacott N, Corbett M, Slack R, Rice S.

●         P2A165: Defining study designs in The Cochrane Collaboration: do all Cochrane Review Groups talk the same language? López-Alcalde J, Calcerrada N, Callejo D, Reza M, Gracia FJ, Maeso S, Escalona S, Nieto B, Fernández de Larrea N, Valentín B, Díaz P, González A, Blasco JA.

●         P2A166: Why and when children are different: guidance on appropriate inclusion of child health data in systematic reviews. Thomson D, Williams K, Hartling L.

●         P2A167: Systematic reviews of complex interventions: from bare bones to greater policy relevance. Snilstveit B, Waddington H.

●         P2A169: Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews. Melnik T, Soares B, Puga E, Atallah A, Rufino C.

●         P2A170: Nonrandomised studies in reviews of effective professional practice and the organisation of health care: Do authors consider them and do they find them? Glenton C, Lewin S, Mayhew A, Scheel IB.

●         P2A171: Determining appropriate inclusion criteria for reviews of public health interventions: skin cancer prevention as a case study. McDaid C, Sowden A, Paton F.

●         P2A172: Piloting realist review methods to assess cost-effectiveness within the context of a systematic review. Anderson R, Pearson M, Shepperd S, Pawson R, Hunt H, Cooper C, Shemilt I.

●         P2A173: Amalgamating individual patient data for meta-analysis: an I.T. perspective. Hilken N, Middleton L, Champaneria R, Daniels J.

●         P2A175: A descriptive analysis of overviews of reviews published between 2000 and 2010. Hartling L, Chisholm A, Thomson D, Dryden DM.

●         P2A176: Methodological challenges associated with network meta-analyses: The experience of the Musculoskeletal Group. Tanjong Ghogomu E, Maxwell L, Singh J, Christensen R, Wells G, Buchbinder R, Tugwell P.

●         P2A177: Are all Cochrane reviews born equal? Methodological quality across different Review Groups. Pantoja T, Moreno G, Mayhew A, Rivera S, Claro JC.

●         P2A178: Systematic reviews of the effectiveness of quality improvement strategies and programmes: some methodological issues. Pantoja T, Mayhew A, Grimshaw J.

●         P2A179: Minimal clinically important differences in acute pain. Tendal B, Ortner N, Gøtzsche PC, Hróbjartsson A.

●         P2A180: Does Patient Expectation Affect Treatment Outcomes?: A Preliminary Investigation on Expectations and Outcomes. Lee H, Zhang X, Cho S, Lee H.

●         P2A181: Consulting with young people to inform systematic reviews: an example from a review on the effects of schools on health. Jamal F, Harden A, Wells H, Bonell C.

●         P2A182: Using systematic reviews to study adverse drug reactions: the example of heparin-induced thrombocytopenia. Junqueira DRG, Carvalho MDG, Perini E.

●         P2A183: A network meta-analysis of randomized controlled trials of target therapy for mRCC. Chan A, Leung H.

●         P2A184: How useful is GRADEpro for assessing evidence from epidemiological or diagnostic accuracy studies. Gholitabar M, Ullman R, Newbatt E, Fields E, Kenny J.

●         P2A185: Systematic reviews in dentistry have problems including split-mouth and cross-over trials in meta-analysis. Carrasco-Labra A, Brignardello-Petersen R, Araya I, Yanine N.

●         P2A186: Designs and Analysis of N-of-1 trials: A systematic review. Perdices M, Barrowman N, Sampson M, Shamseer L, Bukutu C, Vohra S.

●         P2A187: A coherent framework for choosing ‘fit for purpose’ review methods. Oliver S, Thomas J, Gough D.

●         P2A188: Incorporating the GRADE approach in overviews of SR: an example from an overview in neonatal respiratory care. Rojas M, Lozano J, Sola I, Bonfill X.

●         P2A189: A pilot Mixed Methods Appraisal Tool (MMAT) for systematic mixed studies reviews. Pluye P, Cargo M, Robert E, Bartlett G, O’Cathain A, Griffiths F, Boardman F, Gagnon M, Rousseau M.

●         P2A190: Systematic Reviews of Adverse Events. Is Screening by Title and Abstract Enough? Zorzela L, Punja S, Joffe A, Hartling L, Loke Y, Vohra S.

●         P2A194: Challenges facing reviewers preparing overviews of reviews. Flodgren G, Shepperd S, Eccles M.

●         P2A195: GRADE in Cochrane Systematic Reviews : An Investigation. Xiao J, Zhen H, Chen Y, Yuan J, Ke W, Li Y, Li M, Zhao X, Li X, Liu Y.

●         P2A196: Drug reviews should state industry-related bias in abstracts and plain language summaries. Napoli M, Simi S.

 

Investigating bias (P2A197-P2A202) – (Vestíbulo 1er piso)

●         P2A197: Association between risk of bias and the effects of interventions on mortality in of randomized controlled trials in critical care medicine. Unverzagt S, Prondzinsky R.

●         P2A198: Extraction error or interpretation: A case study of event data extraction in systematic reviews from three high-impact, high-quality peer-reviewed sources. Carroll C, Scope A, Kaltenthaler E.

●         P2A199: Heterogeneity in systematic reviews on spinal surgery: a meta-epidemiological study. Jacobs W, Kruyt M, Verbout A, Oner C.

●         P2A200: Attributes of non-randomized studies associated with bias. Sandhu L, Tomlinson G, Kennedy E, Wei A, Baxter N, Urbach D.

●         P2A201: Reporting of participant flow diagrams in published reports of randomized trials. Hopewell S, Hirst A, Collins G, Mallett S, Yu L, Altman D.

●         P2A202: Quality of studies reporting patient-reported outcomes identified within a systematic review on low-dose rate brachytherapy for localized prostate cancer. Peinemann F, Grouven U, Sauerland S.

 

Investigating bias (P2B203-P2B260) – (Vestíbulo 2º piso)

●         P2B203: Systematic reviews of paediatric surgical interventions: quantity, coverage and quality. McGee R, Craig J, Webster A.

●         P2B204: Core outcomes in systematic reviews of paediatric surgical interventions. McGee R, Craig J, Webster A.

●         P2B205: “Fatal flaws” in randomised controlled trials of interventions for low-back pain. Henschke N, Ostelo R, van Tulder M.

●         P2B206: Trends over time in the size and quality of randomised controlled trials of interventions for chronic low-back pain. Henschke N, Kuijpers T, Rubinstein S, van Middelkoop M, Ostelo R, Verhagen A, Koes B, van Tulder M.

●         P2B207: The risk-of-bias and standards of reporting of published randomized controlled trials of medical education (Med Ed) research. Horsley T, Rabb D, Campbell C, Hamstra S, Cook D.

●         P2B208: Are overview of (systematic) review really of good quality and transparent information? Li L, Yang K, Han D, Tian J, Sun T.

●         P2B209: What are the reporting and methodological qualities of network meta-analysis? Li L, Sun T, Han D, Yang K, Tian J.

●         P2B210: Epidemiology and quality of reporting of conference abstracts related to randomized controlled trials in renal transplantation. Wang X, Jiang J, Li L, Tian J, Tian H, Ying X.

●         P2B211: The relationship between risk of bias and effect size: randomized controlled trials. Dolores F, Héctor M.

●         P2B212: Definitions of intention-to-treat in the face of missing outcome data: a systematic survey of methodology papers. Alshurafa M, Guyatt GH, Akl EA, Haines T, Gentles S, Rios L, Tran C, Lamontagne F, Moayyedi P, Walter SD, Briel M.

●         P2B213: Methodological and reporting quality of systematic reviews on influenza. Jiang J, Wang X, Tian.

●         P2B214: Characteristics of randomized controlled trials (RCT) published in Latin America and the Caribbean’s (LAC) in 2010. Reveiz L, Glujovsky D, Pinzon CE, Asenjo-Lobos C, Cortes M, Canon M, Bardach A, Comandé D, Cardona AF.

●         P2B215: Impact of the trial registration initiative in Latin America and the Caribbean’s: a study of randomized controlled trials published in 2010. Reveiz L, Bonfill X, Glujovsky D, Pinzon CE, Asenjo- Lobos C, Cortes M, Canon M, Bardach A, Comandé D, Cardona AF.

●         P2B216: Does the sensitivity of tests for Down Syndrome really decrease with maternal age? A casestudy illustrating the potential impact of loss to follow up on review conclusions. Pennant M, Guo B, Alldred K, Neilson J, Alfreivic Z, Deeks J.

●         P2B217: Split-Mouth and crossover trials in dentistry are neither well differentiated, nor well analyzed or reported. Brignardello-Petersen R, Carrasco-Labra A.

●         P2B218: Are there discipline-specific quality measures? A systematic review of meta-epidemiological studies. Jacobs W, Kruyt M, Moojen W, Verbout A, Oner C.

●         P2B219: Epidemiology and publication history of randomized controlled trials that were discontinued. Blümle A, Kasenda B, Saccilotto R, Briel M, von Elm E.

●         P2B220: Sponsors’ influence on reporting of results in industry-sponsored trials: a comparison of protocols and published papers. Lundh A, Krogsbøll LT, Gøtzsche PC.

●         P2B221: Critical appraisal checklist for systematic reviews of clinical prediction models. Moons KG, Bouwmeester W, Collins G, Mallet S, Altman D, Reitsma J.

●         P2B222: Comparison of adverse effects data derived from different study designs. Golder S, Loke Y, Bland M.

●         P2B223: How do systematic reviews of insulin and drug therapies for diabetes deal with heterogeneity of results? Sun X, Troung J, Dattani N, Wong E, Kapend P, Bianca H, Sherifali D, Wang L, Nereberg K, Guyatt G.

●         P2B224: Sponsorship of drug and device studies and research outcome. Lundh A, Lexchin J, Sismondo S, Busuioc OA, Bero L.

●         P2B225: Adding unpublished Food and Drug Administration (FDA) data changes the results of metaanalyses. Hart BL, Lundh A, Bero LA.

●         P2B226: Overestimation of treatment benefits in single-centre osteoarthritis trials may be related to sample size: meta-epidemiological study. Nüesch E, Trelle S, Reichenbach S, Jüni P.

●         P2B227: Assessing the quality of non-randomised comparative studies: Our experience of using the Cochrane Collaboration’s risk of bias tool. Robertson C, Ramsay C, Gurung T, Mowatt G, Pickard R, Sharma P.

●         P2B228: A meta-epidemiological approach for evaluating bias and small study effects in networks of interventions. Chaimani A, Schmid C, Vasiliadis H, Salanti G.

●         P2B229: First results of a Systematic Review of Metaanalyses on the Efficacy of SSRI and SNRI in the Treatment of Major Depression. Koesters M, Zhang Y, Weinmann S, Cipriani A, Barbui C, Becker T.

●         P2B230: What can we learn from Chinese randomized controlled trials? A systematic review of Chinese venlafaxine studies. Koesters M, Zhang Y, Ma YC, Weinmann S, Becker T, Jin WD.

●         P2B231: Industrial funding of research is associated with practice of survival analysis. Vlassov V, Gemjian E.

●         P2B232: True methodological quality of trials are not reflected in their reporting. Mhaskar R, Magazin A, Soares H, Kumar A, Djulbegovic B.

●         P2B233: Impact of reported vs. actual methodological quality assessment on treatment effect size. Mhaskar R, Magazin A, Kumar A, Djulbegovic B.

●         P2B234: Observer bias in randomised clinical trial with continuous outcomes. An analysis of trials with both blind and nonblind outcome assessors. Hróbjartsson A, Thomsen ASS, Emanuelsson F, Thomsen B, Hilden J, Ravaud P, Boutron I, Brorson S.

●         P2B235: Pooled standardised mean differences and estimated heterogeneity between trials depend on the type of assessment tool analysed: meta-epidemiological study. Da Costa BR, Rutjes AWS, Johnston BC, Nüesch E, Reichenbach S, Guyatt G, Jüni P.

●         P2B236: Methodological adequacy of articles published in two open-access Brazilian cardiology periodicals. Macedo CR, Silva DL, Melnik T, Rachel R, Pedrosa A, Torloni R, Silva EMK, Atallah AN, Puga ME.

●         P2B237: Are We Evaluating Methodological Quality in the Same Way? Comparison of Tools Used in General Health Research and Physical Therapy with the Risk of Bias Tool. Armijo-Olivo S, Ospina M, Rowe B, Hartling L.

●         P2B238: Methodological quality of malaria RCTs conducted in Africa. Lutje V, Gerritsen A, Siegfried N.

●         P2B239: A systematic review on the efficacy of statins in animal model. Pecoraro V, Moja L, Dall’Olmo L, Cappellini G, Liberati A, Garattini S.

●         P2B240: Shifting effects in three randomised controlled trials on music therapy in mental health. Gold C, Erkkilä J, Crawford M.

●         P2B241: Reporting randomized clinical trials in surgery can be improved; a systematic review. Verhagen AP, v Middelkoop M, Rubinstein SM, Jacobs WC, Ostelo RW, Peul W, Koes BW, v Tulder MW.

●         P2B242: Assessing risk of bias in non-randomised studies and incorporating GRADE: Initial experience with a new Cochrane ‘risk of bias’ tool under development. MacLennan S, Imamura M, Dahm P, Neuberger M, Reeves B, MacLennan G, Omar MI, McClinton S, Griffiths L, N’Dow J.

●         P2B243: Conflicting Guidelines for Screening Mammography: Influence of Author’s Specialty and Conflicts of Interest. Burda B, Holmer H, Ogden L, Fu R, Norris S.

●         P2B244: Assessment of trial risk of bias among Cochrane reviews: a cross-sectional analysis. Abou- Setta A, Dryden D, Hamm M, Moher D, Klassen T, Hartling L.

●         P2B245: Does stratification analysis indicate the confounding factors in meta-analysis of observational studies? Naing C, Mak JW.

●         P2B246: Unplanned crossover in randomised controlled trials: consequences for efficacy and safety outcomes. D’Amico R, Bonafede E, Balduzzi S, Longo G, Guarneri V, Piacentini F, Moja L, Liberati A.

●         P2B247: Applicability of R-AMSTAR instrument to appraise systematic reviews. Martínez-Zapata MJ, Rigau D, Selva A, Gich I, Bonfill X.

●         P2B248: How often do decision analyses of interventions agree with matching systematic reviews? Mhaskar R, Georgiev H, Wao H, Kumar A, Djulbegovic B.

●         P2B249: Epidemiology of the type of intention-to-treat reporting in meta-analyses. Montedori A, Bonacini MI, Luchetta ML, Papini D, Rocchi RE, Orso M, Cozzolino F, Abraha I.

●         P2B250: Using AMSTAR to assess the methodological quality of systematic reviews: an external validation study. Parmelli E, Banzi R, Fernandez Del Rio MDP, Minozzi S, Moja L, Pecoraro V, Liberati A.

●         P2B251: Systematic evaluation of the methodology of randomized controlled trials of anticoagulation in patients with cancer. Rada G, Schünemann H, Labedi N, Akl E.

●         P2B252: An online tool to assess the potential impact of missing outcome data on the estimates of treatment effect of trials. Akl E, Agarwal N, Guyatt G.

●         P2B253: Conflict of interest policies for clinical practice guideline organizations do not measure up to IOM standards. Norris SL, Holmer HK, Burda BU, Ogden LA.

●         P2B254: Reporting of conflicts of interest in Cochrane reviews of trials of pharmacological treatments. Roseman M, Bero LA, Coyne JC, Lexchin J, Turner EH, Thombs BD.

●         P2B255: The placebo response in neuropathic pain trials: it’s not what you think. Selph S, Carson S, McDonagh M.

●         P2B256: Concordance of reporting of primary outcomes in abstracts and full text of randomized clinical trials: is there an outcome reporting bias? Ribic C, Lamontagne F, Johnston B, Briel M, You J, Sun X, Busse J, Bassler D, Vera C, Al-Shurafa M, Mills E, Guyatt G, Cook D, Akl E.

●         P2B257: Conflict of interest among clinical practice guidelines authors. Selph S, Holmer H, Ogden L, Norris S.

●         P2B258: Questionable early stopping: case study of supplemental perioperative oxygen and the incidence of surgical site infection. Tikkinen KAO, Garcia-Alamino JM, Devereaux PJ, Guyatt GH, Alonso-Coello P.

●         P2B259: The quality of trials in quality improvement: systematic review of risk of bias in diabetes studies. Ivers N, Tricco A, Turner L, Moher D, Grimshaw J.

●         P2B260: Development of the McHarm: A tool evaluating validity of the collection and reporting of harms. Santaguida P, Keshavarz H, MacQueen G, Levine M, Beyene J, Raina P.

 

Diagnostic test accuracy review methods (P2B261-P2B271) – (Vestíbulo 2º piso)

●         P2B261: Reporting of meta-analyses and systematic reviews of screening tests in China. Tian HL, Tian JH, Yi K, Gou YN, Yang KH.

●         P2B262: Methodological developments and statistic software used in diagnostic systematic reviews in China. Chong L, Sun R.

●         P2B263: Epidemic characteristics and quality of meta-analysis/systematic review in screening test. Tian HL, Gou YN, Yi K, Tian JH, Wang XJ, Yang KH.

●         P2B264: Addressing methodological challenges in evaluating diagnostic tests: combining the “Grading of Recommendations Assessment, Development and Evaluation (GRADE)” approach and the RAND/ UCLA Appropriateness Method to produce clinical recommendations. Ballini L, Vignatelli L, Negro A, Maltoni S, Grilli R.

●         P2B266: Overinterpretation of results in diagnostic test accuracy studies: evidence of “spin”. Ochodo E, de Haan M, Reitsma J, Lotty H, Bossuyt P, Leeflang M.

●         P2B267: What measures of accuracy should we present in DTA reviews? Jameson CM, Whiting PF, Burke M, Ben-Shlomo Y, Sterne JAC.

●         P2B268: Discrepancy in relative test performance due to modelling strategy in comparative diagnostic meta-analysis: a case study. Takwoingi Y, Abba K, Garner P, Deeks J.

●         P2B269: Can generalizability be considered in systematic reviews of diagnostic test accuracy? Scheibler F, Janssen I, Schröer-Günther M, Sauerland S.

●         P2B270: Methodological filters for the identification of delayed cross-sectional studies. Noel-Storr A, Beecher D.

●         P2B271: Adjusting for indirectness in comparative test accuracy meta-analyses. Leeflang MMG, Di Nisio M, Rutjes AWS, Zwinderman AH, Bossuyt PMM.

 

LatinCLEN Sesión de Pósteres 1 – (Vestíbulo 2º piso)
Viernes 21 Octubre 11, 10:30-11:15h

●         L1: Encuesta sobre conocimiento y actitudes de los médicos hacia las Guías de Práctica Clínica en el Instituto Mexicano del Seguro Social. Norma Patricia Constantino Casas, Consuelo Medécigo Micete, Adriana Valenzuela Flores, Arturo Viniegra Osorio, Yuribia Millán Gamez, Laura del Pilar Torres Arreola, Santiago Echeverría Zuno, Fernando Sandoval Castellanos.

●         L2: El proceso de construcción de una escala para medir la elección informada de métodos anticonceptivos entre las mujeres que acuden a un programa de planificación familiar. Patricio Valdés, Ana M. Alarcón, Sergio Muñoz.

●         L3: Una escala válida y fiable para medir la percepción de la elección informada en el Programa de Planificación Familiar. Patricio Valdés, Ana M. Alarcón, Sergio Muñoz.

●         L4: Overuse of indwelling urinary catheter in non-intensive care unit patients in University hospital. Lucieni Oliveira Conterno, Juliana Lobo Andrade, Wallan Mason, Carlos Rodrigues da Silva Filho.

●         L5: Balance de un nuevo modelo de gestión en salud. (OUTSOURCING). Indicadores de gestión hospitalaria 2009-2010. Maracaibo. Zulia-Venezuela 2011. Mónica Chirinos, Ricaurte Salom, Thais Romero, Esther Melendez.

●         L6: Determinantes sociales asociadas a desordenes musculo-esqueléticos: Contribución de etnicidad, genero y nivel socioeconómico a resultados de discapacidad e inflamación articular en pacientes chilenos portadores de estas enfermedades. Ana María Alarcón, Sergio Muñoz, Carlos Martínez, Jossel Gutiérrez, Aldo Vidal.

●         L7: Necesidades en rehabilitación de los niños con discapacidad: Percepción de los niños, los padres y los profesionales de rehabilitación. Jesús Alberto Plata Contreras, Teresita Martínez Restrepo, Carlos Alberto Quintero Valencia.

●         L8: Impacto clínico y asistencial de un programa de diagnóstico y tratamiento rápido del cáncer de pulmón. Anna Selva, Ignasi Bolíbar, Alfonso Torrego, Mª Cinta Pallarès.

●         L9: Ensayo clínico aleatorizado, multicéntrico, controlado, paralelo, simple ciego, con enmascaramiento del tratamiento al evaluador, que evalúa la eficacia del plasma rico en plaquetas (PRP) autólogo en el tratamiento de las roturas musculares. Martínez-Zapata MJ, Orozco LL, Soler R, Rodas G, Balius R, Bosch A, Urrútia G, Bonfill X.

●         L10: Tabaco y nivel de ingresos: Revisión Sistemática y Meta-análisis. Agustín Ciapponi, Ariel Bardach, Demián Glujovsky, Patricia Aruj, Agustina Mazzoni, Luz Gibbons, Bruno Linetzky, Brunilda Casetta.